Ceftazidime-Avibactam Susceptibility of Klebsiella pneumoniae Isolates Obtained from Intensive Care Patients
dc.contributor.author | Senol, Gunes | |
dc.contributor.author | Demirel, Mahmut Mete | |
dc.contributor.author | Gunduz, Ayriz Tuba | |
dc.contributor.author | Akan, Tuba | |
dc.contributor.author | Bicmen, Can | |
dc.contributor.author | Yildirim, Suleyman | |
dc.date.accessioned | 2025-03-20T09:41:35Z | |
dc.date.available | 2025-03-20T09:41:35Z | |
dc.date.issued | 2023 | |
dc.department | İzmir Bakırçay Üniversitesi | |
dc.description.abstract | Objective: Antibiotic resistance encountered in agents causing intensive care unit (ICU) infections is a considerable problem in treatment. In recent years, multiple antibiotic resistances have been detected, especially in Klebsiella pneumonia iso- lates. Infections caused by these bacteria are difficult to handle and have a high mortality. In this study, the in vitro antimicrobial susceptibility rate of ceftazidime/ avibactam (CAZ-AVI). on K. pneumonia isolates obtained from the samples of ICU patients was investigated. Material and Methods: The study is designed as a cross-sectional cohort. CAZ-AVI susceptibility of K. pneumonia isolates obtained from patients diagnosed with ICU infection was studied by disc diffusion method. Results: Among 37 K. pneumonia isolates isolated from 20 blood, 16 bronchial aspi- rate and one urine samples from ICU patients, 31 (83.7%) were found to be CAZ-AVI susceptible and 6 (16.3%) were resistant. 12 of the isolates are panresistant. It was observed that 3 (25%) of the panresistant strains were resistant to CAZ-AVI and 9 (75%) were susceptible. Conclusion: In our study, it was determined that CAZ-AVI showed a low resistance rate even in K. pneumoniae strains that showed multi-antibiotic resistance. It was thought that it could be an alternative treatment option in ICU infections with antibiotic resistance problems. | |
dc.identifier.doi | 10.14744/IGH.2023.85547 | |
dc.identifier.endpage | 88 | |
dc.identifier.issn | 1300-4115 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 84 | |
dc.identifier.trdizinid | 1250547 | |
dc.identifier.uri | https://doi.org/10.14744/IGH.2023.85547 | |
dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1250547 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14034/2004 | |
dc.identifier.volume | 37 | |
dc.indekslendigikaynak | TR-Dizin | |
dc.language.iso | en | |
dc.relation.ispartof | İzmir Göğüs Hastanesi Dergisi | |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_TR_20250319 | |
dc.subject | Enterobacteriaceae | |
dc.subject | drug resistance | |
dc.subject | Ceftazidime/avibactam | |
dc.subject | Klebsiella pneumoniae. | |
dc.title | Ceftazidime-Avibactam Susceptibility of Klebsiella pneumoniae Isolates Obtained from Intensive Care Patients | |
dc.type | Article |